利妥昔单抗联合CHOP方案治疗乙肝病毒携带的淋巴瘤患者：一项诊断与治疗挑战 - Suppr

Suppr

超能文献

Treatment of HBV-carrying lymphoma patients with Rituximab and CHOP: a diagnostic and therapeutic challenge.

作者信息

Skrabs C, Müller C, Agis H, Mannhalter C, Jäger U

出版信息

Leukemia. 2002 Sep;16(9):1884-6. doi: 10.1038/sj.leu.2402567.

DOI:10.1038/sj.leu.2402567

PMID:12200717

Abstract

摘要

相似文献

Treatment of HBV-carrying lymphoma patients with Rituximab and CHOP: a diagnostic and therapeutic challenge.

Leukemia. 2002 Sep;16(9):1884-6. doi: 10.1038/sj.leu.2402567.

Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.

J Clin Oncol. 2009 Feb 1;27(4):605-11. doi: 10.1200/JCO.2008.18.0182. Epub 2008 Dec 15.

Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas.

Rheumatology (Oxford). 2004 Aug;43(8):1050-3. doi: 10.1093/rheumatology/keh248. Epub 2004 Jun 8.

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.

N Engl J Med. 2002 Jan 24;346(4):235-42. doi: 10.1056/NEJMoa011795.

Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).

J Clin Oncol. 2005 Mar 20;23(9):1984-92. doi: 10.1200/JCO.2005.08.133. Epub 2005 Jan 24.

Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis.

Ann Hematol. 2011 Oct;90(10):1219-23. doi: 10.1007/s00277-011-1241-0. Epub 2011 Apr 26.

CHOP plus rituximab--balancing facts and opinion.

N Engl J Med. 2002 Jan 24;346(4):280-2. doi: 10.1056/NEJM200201243460411.

Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP.

Ann Hematol. 2004 Dec;83(12):769-74. doi: 10.1007/s00277-004-0899-y. Epub 2004 Aug 25.

Fulminant B hepatitis in a surface antigen and hepatitis B DNA-negative patient with diffuse large B-cell lymphoma after CHOP chemotherapy plus rituximab.

Leuk Lymphoma. 2007 Feb;48(2):431-3. doi: 10.1080/10428190601059704.

Combined treatment with rituximab and anthracycline-containing chemotherapy for primary cutaneous large B-cell lymphomas, leg type, in elderly patients.

Arch Dermatol. 2010 Jan;146(1):89-91. doi: 10.1001/archdermatol.2009.345.

引用本文的文献

Humanized anti-CD19 chimeric antigen receptor-T cell therapy is safe and effective in lymphoma and leukemia patients with chronic and resolved hepatitis B virus infection.

Hematol Oncol. 2021 Feb;39(1):75-86. doi: 10.1002/hon.2807. Epub 2020 Oct 1.

Reactivation of occult hepatitis B virus infection in patients with rheumatic diseases: pathogenesis, risk assessment and prevention.

Rheumatol Int. 2016 May;36(5):635-41. doi: 10.1007/s00296-015-3395-x. Epub 2015 Nov 16.

Hepatitis B virus reactivation with a rituximab-containing regimen.

World J Hepatol. 2015 Sep 28;7(21):2344-51. doi: 10.4254/wjh.v7.i21.2344.

Risk of Reverse Seroconversion of Hepatitis B Virus Surface Antigen in Rituximab-Treated Non-Hodgkin Lymphoma Patients: A Large Cohort Retrospective Study.

Medicine (Baltimore). 2015 Aug;94(32):e1321. doi: 10.1097/MD.0000000000001321.

Reactivation of resolved infection with the hepatitis B virus immune escape mutant G145R during dasatinib treatment for chronic myeloid leukemia.

Int J Hematol. 2015 Sep;102(3):379-82. doi: 10.1007/s12185-015-1788-y. Epub 2015 Apr 5.

Hepatitis B virus reactivation with rituximab-containing regimen.

World J Hepatol. 2013 Nov 27;5(11):612-20. doi: 10.4254/wjh.v5.i11.612.

Clinical analysis and prognostic significance of hepatitis B virus infections for diffuse large B-cell lymphoma with or without rituximab therapy.

Exp Ther Med. 2013 Jul;6(1):109-114. doi: 10.3892/etm.2013.1079. Epub 2013 Apr 25.

Rituximab administration and reactivation of HBV.

Hepat Res Treat. 2010;2010:182067. doi: 10.1155/2010/182067. Epub 2010 Dec 1.

A case of lamivudine-sensitive de novo acute hepatitis B induced by rituximab with the CHOP regimen for diffuse large B cell lymphoma.

Hepatol Int. 2009 Mar;3(1):316-22. doi: 10.1007/s12072-008-9094-x. Epub 2008 Sep 23.

Clinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma.

BMC Cancer. 2008 Apr 23;8:115. doi: 10.1186/1471-2407-8-115.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验